Groundbreaking HIV Prevention: Biannual Lenacapavir Injections Launch in African Nations

Dec 01, 2025 09:50 pm CST

South Africa, Eswatini, and Zambia have begun administering lenacapavir, a revolutionary HIV prevention injection taken just twice yearly with 99.9% effectiveness. The rollout marks a significant advancement in HIV prevention across Africa, which bears the world's highest HIV burden. While initial distributions are limited, generic versions are expected by 2027 at approximately $40 annually, potentially transforming HIV prevention in regions where daily PrEP pills have shown limited impact.